drugset / Trial / NCT00728481
The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary aim of this study was to determine the proportion of patients with esophageal eosinophilic infiltration that have objective (measurable) evidence of gastroesophageal reflux disease (GERD). This study was also done to see if patients that have eosinophilic esophagitis (EE) and GERD would receive relief from taking the medication Nexium or a steroid called Pulmicort. The study also evaluated the accuracy of pH monitoring (acid exposure) within the esophagus as a predictor of endoscopic, histological and symptomatic response in patients with EE.
Timeline
- Start
- 2008-05
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Budesonide | Small molecule | 1 g | Oral |
| Comparator | Esomeprazole | Small molecule | 40 mg | Oral |